Navigation Links
Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
Date:10/5/2010

c reports on Form 10- Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of Oct. 5, 2010 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015 Transparency Market Research ... Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... market report published by Transparency Market Research " Non-invasive ... Share, Growth, Trends and Forecast 2014 - 2022 ", ...
(Date:8/4/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/nl392k/alcohol ) has announced ... Application (Household & Personal Care, Pharmaceutical, Oilfield, Agrochemicals, and ... report to their offering. The ... million in 2014 and is projected to grow at ... The data mentioned in the report is based on ...
(Date:8/4/2015)... 2015  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX ), ... of cancer, will be presenting at the 2015 Wedbush PacGrow ... ET (10:55 a.m. PT) in New York ... CEO of Mirati, will provide a corporate overview. ... on the "Investors" page of Mirati,s corporate website at ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3
... 2012  Novation, the leading health care supply contracting ... Transcatheter Cardiovascular Therapeutics Report .  This report ... intended to help VHA, UHC and Provista members ... The Novation cardiology team compiled this report ...
... (Pinksheets: APHY), a leading specialty pharmacy group providing prescription ... Anda,s 2012 Supply Chain Symposium on Thursday, April 19th ... Beach Gardens, Florida.  Assured Pharmacy has been asked to ... substances at pharmacies.   Anda was established ...
Cached Medicine Technology:Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies 2Assured Pharmacy to Present at Anda's 2012 Supply Chain Symposium 2Assured Pharmacy to Present at Anda's 2012 Supply Chain Symposium 3
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard to look ... Day Spa in Santa Barbara, CA is offering the solution by offering an ... eliminates sweat and odor glands in the underarms. This simple and permanent solution ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent ... locations have shown a rise in binge drinking among certain populations ... and depression, are continuing to examine trends and evidence to help facilitate health ...
(Date:8/4/2015)... ... , ... They say a picture is worth a thousand words, and when ... can be essential. StayWell, a health solutions company, announced today it will license KramesArt™ ... used by physicians and other health care providers for more than 40 years and ...
(Date:8/4/2015)... Louis, Missouri (PRWEB) , ... August 04, 2015 ... ... Texting (IAT) solutions, today announced that Bruce McCalley joins its executive leadership team ... track record of sales success at technology companies and expanding global markets with ...
(Date:8/4/2015)... ... August 04, 2015 , ... Providigm, LLC, a developer ... today announced details of the Advanced level of their national accreditation for Quality ... QAPI Accreditation program , introduced in 2013, is based on standards for excellence ...
Breaking Medicine News(10 mins):Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3
... students and faculty of Indian origin add to the rich ... some 430 km from here, where a gunman went on ... professor of Indian origin. ,Founded in 1872, the ... formally called, has more than 25,000 students from as many ...
... footage on television could intensify stress and trauma, according to// ... terrorist attacks on Sep 11, 2001 in the US, sleep ... Andover, Massachusetts, US, began teaching a class in which students ... remembered them. ,On the day after the ...
... According to Irish researchers, a smoking ban which began March ... a drastic cut //in air pollution, the health of bar ... the researchers gave an 83 percent reduction in air pollution ... addition, the report, which was published in the American Journal ...
... known as otitis media with effusion, which consists// of fluid ... ear infection, according to a report in the April issue ... JAMA/Archives journals. ,Otitis media with effusion, a ... space, but without earache, fever or other symptoms, has become ...
... causal organisms of hitherto common diseases// into ‘superbugs’. This, ... , One such example is the recent announcement by ... has now become resistant to the antibiotic fluoroquinolones. The ... creating worry lines on many a health expert. ...
... daily calcium intake is an effective way of identifying ... of osteoporosis, according to a research.// ,Researchers ... looked at a cross-section of 372 men with prostate ... and 28 per cent had undergone a radical prostatectomy. ...
Cached Medicine News:Health News:Indians Add to Rich Diversity of Virginia Tech 2Health News:Disturbing TV Scenes may Intensify Stress 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:Obesity may Be Linked to Middle Ear Effusions in Children 2Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
... the qualitative differential detection ... antigen and an antigen that ... species of malaria:plasmodium falciparum (P.f), ... (P.o) and Plasmodium malariae (P.m) ...
Medicine Products: